Drug Profile
Recombinant batroxobin
Alternative Names: rBATLatest Information Update: 26 Jan 2011
Price :
$50
*
At a glance
- Originator Sinobiomed
- Class Coagulants; Crotalid venoms; Recombinant proteins; Serine endopeptidases
- Mechanism of Action Fibrinogen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Haemorrhage; Surgical blood loss